Learn More
Medchemexpress LLC Dbco-peg4-mmaf | 2360411-65-8 | 99.8% | 1266.56 g·mol⁻¹ | C69H99N7O15 | 5 MG

Supplier: Medchemexpress LLC HY1334925MG
DBCO-PEG4-MMAF is a drug-linker conjugate used in antibody-drug conjugate research. It contains a dibenzocyclooctyne (DBCO) reactive group connected via a four-unit polyethylene glycol (PEG4) linker to the tubulin inhibitor MMAF, enabling strain-promoted alkyne-azide cycloaddition (SPAAC) for bioconjugation.
- Contains DBCO reactive group for SPAAC click chemistry.
- PEG4 spacer provides flexibility and improved solubility.
- Includes MMAF payload, a potent tubulin polymerization inhibitor.
- High purity and provided as a solid, white to off-white powder.
- Available in small research pack sizes suitable for conjugation workflows.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.